Dr Cori Cross (Host): This is Pediatric Insights, advances in Innovations with
Children's Health, where we explore the latest in pediatric care and research.
I'm your host, Dr.
Cory Cross.
Today we'll discuss when primary care providers should
refer to an endocrinologist.
We are excited to have Dr.
Nadia Merchant, who is a pediatric boarded endocrinologist and geneticist
at Children's Health and an associate professor at UT Southwestern with us today
to give us guidance and to discuss the key skeletal growth signs that signal the need
for a pediatric endocrinology referral.
Thank you, Dr.
Merchant, for being with us today.
Dr Nadi Merchant: Thank you for having me.
Dr Cori Cross (Host): So Dr.
Merchant, as a primary care physician, we start plotting and charting children's
growth from like the moment they arrive and we're tracking them And we know if
they're on a low curve or we know if they fall from one curve to another.
But there's a lot to consider and sometimes we have a lot of questions
from parents as to when to refer.
When should a primary care provider think about referring to an endocrinologist?
Dr Nadi Merchant: So there are the obvious signs, such as if they look
disproportionate in general or.
Slight dysmorphology.
That may be concerning, but also I think what we're talking a lot about
is a child that has no past medical history looking great, but falling
off the ger chart, so maybe decreased growth velocity, falling in percentiles.
Those are all reasons I would say should refer to endocrinology in general.
Dr Cori Cross (Host): So Those are not times where we should say, Hey,
This is constitutional growth delay.
Let's give it six months to a year and see if you pop back up.
We should be making those referrals quickly.
Correct.
Dr Nadi Merchant: Yes, Those are the referrals I think are more
necessary as soon as you notice them.
Dr Cori Cross (Host): Got it.
And now some signs may be more nuanced.
Is there anything particularly that we should be looking for or
any obvious physical features that may indicate a skeletal or genetic
issue that warrants consult?
Okay.
Dr Nadi Merchant: One of the signs that I always say is if mom, during
her pregnancy was told, the baby's not growing as well, especially if
there was small and like femur length.
And That is one I would say should be referred.
The other is if you feel the child is disproportionate, in one way or the other.
So is it extremities, disproportionate, proportionate or not?
And a large head circumference sometimes can make you think of
a skeletal dysplasia and those require more appropriate referrals.
Dr Cori Cross (Host): Got it.
And so I'm a pediatrician And so I have a question.
Like I was taught that something like constitutional growth delay is just
sometimes kids, for whatever reason, genetic or whatnot, just sort of.
Stop growing And then there'll be like late bloomers.
Is that actually true or is that just an old wives tale?
Dr Nadi Merchant: So constant growth delay is true.
And I think I like to get a history like when did mom have menarchy?
Did dad was a late bloomer or not?
Did he grow after high school?
So Those are sometimes.
signs that I'll say, oh, you were a late bloomer.
And then if you see the child's growing slightly off in percentile, but they're
relatively on the growth chart, Those are more signs that may not need referral
if they just have cause or growth delay.
the other thing I would say is, are they still growing?
If you have no growth rate or less than three centimeters per year.
Then that might require a referral or some lab work that will say there's
something going on compared to a child who's growing four to five centimeters a
year and maybe not making it on the, where everybody else is going through puberty.
And this kid is not sirens, puberty.
Dr Cori Cross (Host): Got it.
Now, have there been changes to really the thought process on treating short stature?
So before it was obviously not treatable, but now with, growth hormone and with
puberty blockers, there's the ability to actually change someone's stature.
Have there been changes really in the thought process on the endocrine side?
I know there are changes on the parental side, as to when This is
appropriate and not appropriate.
Dr Nadi Merchant: So if the child is less than.
Z-score or, negative 2.25
or like less than third percentile.
That's what we would call idiopathic short stature.
And That is approved indication for growth hormone as such.
But that doesn't mean it's always given because we have to
put some thought process to it.
So every child is not gonna be on growth hormone.
Just because they're slightly shorter and they don't always have great improvement
or even respond to growth hormone.
So there are indications that are specific based on genetic conditions or where
they're on the growth chart, or if they have growth hormone deficiency where
they don't make enough growth hormone.
Dr Cori Cross (Host): Now when you say they don't always respond, is that
something that's doses dependent or is that something that's patient dependent?
Dr Nadi Merchant: It's patient dependent.
I have some kids I've put on growth hormone and they did not
improve in their growth velocity.
Sometimes they started going through puberty, so that improved, but it wasn't
the growth hormone that was helping.
Dr Cori Cross (Host): Got it.
And so the other thing I wanted to ask is we have become much more sophisticated in
our treatment of short stature, whether it's idiopathic or for other reasons.
How has that changed?
Because I remember that one of the big concerns was the
sequela of these medications, the sequela of giving growth hormone.
How has that changed as we've become more sophisticated with our
dosage and our treatment plans?
I.
Dr Nadi Merchant: So we have different dosage that we
give based on the indication.
So for certain genetic conditions, the dosage may be higher And for like
growth hormone and deficiency, sometimes the kids are on a much lower dose.
And then for what we call idiopathic short stature, the dosage we use has to be.
higher dose, but then I'm always concerned am I gonna cause side effects
by giving too much growth hormone.
Dr Cori Cross (Host): And what are those possible side effects?
Dr Nadi Merchant: So you can have increased intracranial pressure
in a sense like when you give too much, the kids can get headaches.
there is always the risk of scfe, slipped capital femoral epiphysis
where it can happen in any child.
But if you give growth hormone, there is a higher risk.
And honestly, growth hormone was only even around since the late 1980s.
We don't know what the long-term effects are.
And so if I don't need to give it to a child, I'm always
hesitant to give growth hormone.
Dr Cori Cross (Host): And is it associated with any sort of increased risk of
stroke or heart disease or cancers later in life, or is that not true?
Dr Nadi Merchant: There is some maybe data That is there, but I think that it's hard
for us to say, And also we don't follow healthy children that we put on growth
hormone into their forties and fifties.
So really I have a hard time saying, will it cause problems in the future?
But there are some papers out there that maybe say yes.
Dr Cori Cross (Host): So as a pediatrician, if I have a parent who
comes to me who says they just don't want their, son to be five seven, I
should not refer to endocrinology if that's part of their mid parental height.
And they've had no dropping off the growth curve because
we are tinkering with the body.
Dr Nadi Merchant: I agree.
I think that also plotting the child on the growth chart with the mid
parental height and sometimes even getting a bone age and showing, oh
look, your child's bone age just.
Fine for your family or they're delayed.
Can help explain to the family And the child why they are where they
are on the growth chart, I think that everybody thinks that they're supposed
to be six foot tall, but if your mid parental height is around five
four, I can't make you six foot tall.
Even if I put you on growth hormone.
Dr Cori Cross (Host): That makes sense.
So let's take a moment to discuss the future of what you see on the horizon.
Are there any advancements or emerging treatments in this field that you and
your team are participating in that you're particularly excited about?
Dr Nadi Merchant: so now we have a lot more research.
Specifically on genetic growth, short stature, which includes what we would
thought was idiopathic short stature.
There's certain genes we've discovered that really lead to short stature and
there've been some new drugs that are in development one, this ide that's been
approved by the FDA for achondroplasia And that works at the growth plate level and
those drugs are now being clinical trial.
For certain genetic causes of short stature and currently also
for idiopathic short stature, which is less than negative 2.25
standard deviation on the Z-score.
And so we're, part of the clinical trials, but I think there's a lot
to come in the horizon because we're doing a lot of genetic testing
on kids that are truly short.
Dr Cori Cross (Host): That's amazing.
And so what percentage of short stature do you think is actually
incorporated in our genetics?
Dr Nadi Merchant: So there are total genome white association studies that
have been done, And we know there's a lot of genes that contribute to 1%
of our height, So that's one thing that we've discovered, but then there
are certain genes that we don't even realize it, that can make you on the
third percentile or slightly shorter.
And there's genes like IHH and NPR two And that are leading to shorter stature.
And there's some great studies coming out.
there's some studies coming from Brazil and from the US that are really doing
whole genome to see whether or not we can understand what causes short stature.
compared to just saying it's idiopathic.
Dr Cori Cross (Host): That's really amazing and very exciting.
So for you, you care for some medically complicated children,
and I'm sure that requires a lot of communication between providers.
How does your team collaborate with referring providers and specialty
clinics to really coordinate care for these children and their parents?
Dr Nadi Merchant: So we are starting a skeletal dysplasia
multidisciplinary clinic.
in the past, if there was a child with Achondroplasia, they would go
to whichever doctor they need to go to based on where the patient or
the family thought they need to go or who, which referrals were done.
But now we're trying to make sure that these patient's Have
a ringleader, and that's kind of what we're doing is I'm being the
ringleader for my skeletal dysplasia patient's and it starts prenatally.
Now, there's advancement in genetic testing, as we have non-invasive
prenatal testing now in that can diagnose certain skeletal disorders.
Prenatally.
So I do consultations for those And then I'll meet with the family before
they even have the child and kind of walk them through what to expect.
And then we'll coordinate all the referrals that could include sleep
medicine, neurosurgery, MRIs, if there are certain risks that need to be done, ENT.
And so we're trying to make sure these children To optimize their care
they're getting, but also now that there's new trials and there's, f
FDA-approved treatments, we discuss whether or not a family would want to
do it, why would they not want to do it, versus using some of these therapies.
Dr Cori Cross (Host): That's amazing because I think as a parent it's so
hard to coordinate everything, but then also to make sure that you're not having
any of the kids slip through cracks.
And there often is a limited time when you can, utilize their growth
to really get to where you wanna go.
And if you miss that window, you really can't go back.
Dr Nadi Merchant: Yes, and with certain skeletal dysplasias, like
achondroplasia, there's a much higher risk of sudden infant death, which
is due to foreign magnus stenosis.
So I wanna see those babies as soon as they're born.
And like ideally they would leave the hospital.
With an appointment with me so that way I can coordinate like they
need to make sure their car seat's working properly for this child.
They know they get the MRI sleep medicine because we wanna make sure that
their, for stenosis is not so severe.
And a lot of the times these kids get diagnosed later, it takes
forever to get an appointment.
So the goal is that we.
Getting the care as early as possible, for these children.
And there's a lot of other scale dysplasias that obviously are there,
but they, canplas is one that we know is really important during
infancy to be managed appropriately.
Dr Cori Cross (Host): That's amazing Dr.
Merchant.
Give us a 32nd wrap up take-home message for our listeners.
Dr Nadi Merchant: Growth is such an important part of childhood.
The pediatrician is following them since they're born making sure
they're growing appropriately and.
Poor growth can mean they have a chronic condition or they could have growth
hormone deficiency or a skeletal disorder.
And so I think that the general pediatrician is really the person who
refers to the appropriate provider.
And it could be endocrinology, it could be gi, it could be whoever That is
appropriate to make sure that this child's getting the optimal care to make sure
they're going to grow as they should.
Dr Cori Cross (Host): Thank you, Dr.
Merchant.
That is such great advice, and thank you for taking the
time to speak with us today.
Dr Nadi Merchant: Thank you for having me today.
Dr Cori Cross (Host): If you would like more information about the endocrinology
clinic at Children's Health, please visit children's dot com slash endocrinology.
Thank you so much for your time with us today, And for our audience for
listening to Pediatric Insights, advances in Innovations with Children's
Health, where we explore the latest in pediatric care and research.
You can find more information at children's dot com.
And if you found this podcast helpful, please rate, review and share this
episode, and please follow Children's Health on your social channel.